ARCHIVES

Mace Rothenberg Leaves Vanderbilt For Pfizer Oncology.

This article is from The Cancer Letter archive.

Vol. 34 No. 42 | November 14, 2008

Download PDF Visit The Full Archive

Related Articles

IOM Omics Committee Offers Blueprint to Prevent Other Duke-Style Disasters

March 23, 2012

Radio-Immunotherapy Advances May Rival Those With Drugs

April 16, 1976

Bush Signs HHS Appropriations; NCI Budget $4.188B After Administrative Rescission.

January 11, 2002

NSABP Accrual Slow, But Auditing Called “Impressive”

January 20, 1995

Enzastaurin Shows Activity In Recurrent High-Grade Glioma

June 24, 2005

Clinical Trials: ECOG Says Results In Metastatic disease equivalent, Unlikely To change Over Time

April 16, 1999